Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
52.04 EUR | -0.80% | -1.33% | -11.77% |
09-02 | Eurofins Scientific: new share buyback program | CF |
09-02 | Eurofins Scientific Launches New Share Buyback Program | MT |
Business description: Eurofins Scientific SE
At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world.
Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).
Number of employees: 61,798
Sales by Activity: Eurofins Scientific SE
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Analytical Testing | 4.56B | 5.44B | 6.72B | 6.71B | 6.51B |
Geographical breakdown of sales: Eurofins Scientific SE
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Europe | 2.53B | 3.18B | 4.05B | 3.56B | 3.36B |
North America | 1.7B | 1.92B | 2.18B | 2.53B | 2.54B |
Rest of The World | 401M | 425M | 603M | 733M | 725M |
Group Service Functions | - | - | - | - | 100K |
Inter-Segment Revenues | -73.4M | -84.2M | -114M | -112M | -111M |
Managers: Eurofins Scientific SE
Director | Title | Age | Since |
---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 61 | 31/12/86 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 31/12/14 |
Christian Wurst
COO | Chief Operating Officer | - | 30/09/19 |
Corporate Officer/Principal | 41 | - | |
François Vigneau
PRN | Corporate Officer/Principal | 58 | 31/10/96 |
Members of the board: Eurofins Scientific SE
Manager | Title | Age | Since |
---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 61 | 31/12/86 |
Yves-Loïc Martin
BRD | Director/Board Member | 58 | 31/12/91 |
Valérie Hanote
BRD | Director/Board Member | 58 | 31/12/90 |
Director/Board Member | 60 | 19/04/17 | |
Pascal Rakovsky
BRD | Director/Board Member | 65 | 31/05/20 |
Evie Roos
BRD | Director/Board Member | 57 | - |
Ivo Rauh
BRD | Director/Board Member | - | - |
Erica Monfardini
BRD | Director/Board Member | - | - |
Holdings: Eurofins Scientific SE
Name | Equities | % | Valuation |
---|---|---|---|
EUROFINS CEREP 95.76% | 4,831 | 95.76% | 113,365,596 $ |
EUROFINS SCIENTIFIC SE 0.50% | 955,858 | 0.50% | 54,637,140 $ |
VIMTA LABS LIMITED 19.86% | 4,403,668 | 19.86% | 32,857,705 $ |
Company details: Eurofins Scientific SE
Group companies: Eurofins Scientific SE
Name | Category and Sector |
---|---|
Eurofins GeneScan Holding GmbH
Eurofins GeneScan Holding GmbH Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins GeneScan Holding GmbH is a world leader in food, environment, pharma product testing & agroscience CRO services. The company is based in Freiburg im Breisgau, Germany. The German company has a network of more than 1,000 independent companies (900 laboratories) in 61 countries, offering over 200,000 analytical methods. The company was founded in 2011 and the CEO is Gilles G. Martin. |
Miscellaneous Commercial Services
|
Wiener Neudorf Palmersstraße Real Estate GmbH
|
Other Healthcare Facilities & Services
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-0.80% | -1.33% | -4.16% | -57.21% | 11.08B | ||
+0.78% | -1.53% | +50.14% | +52.58% | 101B | ||
+2.53% | -0.93% | -18.42% | -31.34% | 72.37B | ||
+1.50% | -3.63% | +26.38% | +66.11% | 27.7B | ||
+3.31% | +4.91% | +21.68% | -16.19% | 20.94B | ||
+0.81% | -3.20% | +9.16% | -26.88% | 18.48B | ||
+0.78% | +0.34% | +21.64% | -0.12% | 17.23B | ||
+1.04% | +6.49% | +129.28% | +4.14% | 15.48B | ||
+0.69% | -3.32% | +82.35% | +56.93% | 15.43B | ||
+0.22% | -2.45% | +123.62% | +117.32% | 15.14B | ||
Average | +0.83% | -0.99% | +44.17% | +16.53% | 31.49B | |
Weighted average by Cap. | +0.56% | -1.25% | +33.53% | +19.45% |
Sector
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ERF Stock
- Company Eurofins Scientific SE
MarketScreener is also available in this country: United States.
Switch edition